Fenbendazole

This classification denotes an antihelminthic agent with the molecular formula C15H13N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 621BVT9M36, chemically known as 2-benzimidazolecarbamic acid, 5-(phenylthio)-, methyl ester but generally known as fenbendazole, which bears US NIH Compound Identifier 3334. European Medicines Agency schedules Fenbendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07541MIG. The term FENBENDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules fenbendazole in its Anatomical Therapeutic Chemical (ATC) Classification. FENBENDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fenbendazole under HS 29339990 and SITC 51577. As of Q4 2014, FENBENDAZOLE remains the US FDA Preferred Term for this commodity. Fenbendazole bears US NLM identifiers UMLS ID C0015821 and NCI Concept Code C75218. SMILES: S(C1CC2[NH]C(NC2CC1)NC(=O)OC)C1CCCCC1.